4-aminopyridine Fails to Improve Muscle Function in SMA Type 3 Patients & New Service Dog
Oct 19, 2020, 12:00 AM
SMA News Today’s multimedia associate, Price Wooldridge, discusses 4-aminopyridine’s failure to improve muscle function in SMA Type 3 patients.
DeAnn Runge talks about how her new service dog Horton is adjusting to life in Minnesota.
Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/